Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults

[1] Smitherman TA(2013)The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies Headache: The Journal of Head and Face Pain 53 427-436

[2] Burch R(2017)National trends in direct health care expenditures among US adults with migraine: 2004 to 2013 J Pain 18 96-107

[3] Sheikh H(2008)Acute and prophylactic treatments for migraine: present and future Neurol Sci 29 110-122

[4] Loder E(2008)Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults Cephalalgia. 28 484-495

[5] Raval AD(2012)Renin angiotensin system: a novel target for migraine prophylaxis Indian J Pharm 44 157-192

[6] Shah A(2009)Pathophysiological basis of migraine prophylaxis Prog Neurobiol 89 176-1679

[7] Rapoport AM(2009)Telmisartan: a different angiotensin II receptor blocker protecting a different population? J Int Med Res 37 1662-E276

[8] Silberstein S(2010)Prophylaxis of migraine headache Canadian Medical Association Journal 182 E269-532

[9] Tfelt-Hansen P(2014)A comparative study of candesartan versus propranolol for migraine prophylaxis: a randomised, triple-blind, placebo-controlled, double cross-over study Cephalalgia. 34 523-927

[10] Dodick DW(2009)Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial Cephalalgia. 29 921-69

[1] Smitherman TA(2013)The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies Headache: The Journal of Head and Face Pain 53 427-436

[2] Burch R(2017)National trends in direct health care expenditures among US adults with migraine: 2004 to 2013 J Pain 18 96-107

[3] Sheikh H(2008)Acute and prophylactic treatments for migraine: present and future Neurol Sci 29 110-122

[4] Loder E(2008)Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults Cephalalgia. 28 484-495

[5] Raval AD(2012)Renin angiotensin system: a novel target for migraine prophylaxis Indian J Pharm 44 157-192

[6] Shah A(2009)Pathophysiological basis of migraine prophylaxis Prog Neurobiol 89 176-1679

[7] Rapoport AM(2009)Telmisartan: a different angiotensin II receptor blocker protecting a different population? J Int Med Res 37 1662-E276

[8] Silberstein S(2010)Prophylaxis of migraine headache Canadian Medical Association Journal 182 E269-532

[9] Tfelt-Hansen P(2014)A comparative study of candesartan versus propranolol for migraine prophylaxis: a randomised, triple-blind, placebo-controlled, double cross-over study Cephalalgia. 34 523-927

[10] Dodick DW(2009)Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial Cephalalgia. 29 921-69